Pharmacological management of patients with diagnosed AAA includes prescription of lipid-lowering statins, angiotensin II receptor blockers (ARBs), and angiotensin-converting enzyme (ACE) inhibitors as antihypertensive therapy. The gene discussed is ACE; the disease is triple-A syndrome.